-
-
-
-
-
-
-
Masimo gets FDA clearance for opioid respiratory risk detection
-
-
-
-
-
-
-
SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
-
-
-
-
-
-
-
Danaher prices €3 billion euro-denominated senior notes offering
-
-
-
-
-
-
-
Masimo to be Acquired by Danaher for $180.00 Per Share
-
-
-
-
-
-
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
-
-
-
-
-
-
Danaher Reports Second Quarter 2025 Results
-
-
-
-
-
-
-
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
-
1,197,112 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


